Genomma Lab InternacionalB de CV (MEX:LABB) EV-to-Revenue : 1.23 (As of Jun. 25, 2024)

View and export this data going back to 2008. Start your Free Trial

What is Genomma Lab InternacionalB de CV EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Genomma Lab InternacionalB de CV's enterprise value is MXN20,350 Mil. Genomma Lab InternacionalB de CV's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was MXN16,486 Mil. Therefore, Genomma Lab InternacionalB de CV's EV-to-Revenue for today is 1.23.

The historical rank and industry rank for Genomma Lab InternacionalB de CV's EV-to-Revenue or its related term are showing as below:

MEX:LABB' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.99 Med: 1.84 Max: 3.89
Current: 1.23

During the past 13 years, the highest EV-to-Revenue of Genomma Lab InternacionalB de CV was 3.89. The lowest was 0.99. And the median was 1.84.

MEX:LABB's EV-to-Revenue is ranked better than
72.13% of 1019 companies
in the Drug Manufacturers industry
Industry Median: 2.16 vs MEX:LABB: 1.23

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-25), Genomma Lab InternacionalB de CV's stock price is MXN16.63. Genomma Lab InternacionalB de CV's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was MXN16.94. Therefore, Genomma Lab InternacionalB de CV's PS Ratio for today is 0.98.

Genomma Lab InternacionalB de CV EV-to-Revenue Historical Data

The historical data trend for Genomma Lab InternacionalB de CV's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomma Lab InternacionalB de CV EV-to-Revenue Chart

Genomma Lab InternacionalB de CV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

1.90

1.70

1.26

1.09

Genomma Lab InternacionalB de CV Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															1.11	1.03	1.01	1.09	1.21

Competitive Comparison of Genomma Lab InternacionalB de CV's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Genomma Lab InternacionalB de CV's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genomma Lab InternacionalB de CV's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Genomma Lab InternacionalB de CV's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Genomma Lab InternacionalB de CV's EV-to-Revenue falls into.

Genomma Lab InternacionalB de CV EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Genomma Lab InternacionalB de CV's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	20349.940	/	16486.218
	=	1.23

Genomma Lab InternacionalB de CV's current Enterprise Value is MXN20,350 Mil.
Genomma Lab InternacionalB de CV's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN16,486 Mil.

Genomma Lab InternacionalB de CV (MEX:LABB) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Genomma Lab InternacionalB de CV's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	16.63	/	16.944
	=	0.98

Genomma Lab InternacionalB de CV's share price for today is MXN16.63.
Genomma Lab InternacionalB de CV's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN16.94.

Genomma Lab InternacionalB de CV EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Genomma Lab InternacionalB de CV's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Genomma Lab InternacionalB de CV (MEX:LABB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genomma Lab Internacional SAB de CV (MEX:LABB) » Definitions » EV-to-Revenue

Traded in Other Exchanges

GNMLF:USA GEKA:Germany

Address

Avenida Antonio Dovalí Jaime, Number 70, Tower C, Floor 2, Office A. Colonia Santa Fe, Del. Alvaro Obregon, Mexico, MEX, MEX, CP 01210

Website

https://www.genommalab.com

Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Genomma Lab InternacionalB de CV (MEX:LABB) Headlines

No Headlines